The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
FREQUENCY AND CHARACTERISTICS OF INTRAOCULAR INFLAMMATION AFTER AFLIBERCEPT INJECTION
Abstract
In Brief Purpose: To report the frequency and characteristics of intraocular inflammation after intravitreal aflibercept injection. Methods: A single-center retrospective study was performed in patients who received intravitreal aflibercept from November 2011 through June 2013. Results: There were 28 cases of intraocular inflammation after a total of 5,905 aflibercept injections among 1,660 patients. The mean baseline acuity was 20/57, which decreased to 20/179 at diagnosis (P < 0.0001) but recovered to 20/59 at Month 1, 20/57 at Month 3, and 20/52 at Month 6 (P = not significant). Vitreous culture and injection of antibiotics were performed in eight cases, and all were culture negative; the remainder received only topical corticosteroids. Conclusion: The frequency of inflammation after aflibercept was 0.47% per injection. Visual acuity and inflammation returned to baseline within 1 month in most cases with topical corticosteroid treatment. The rate of intraocular inflammation after aflibercept injection was 0.47%, with 28 cases in 5,095 consecutive injections; although presenting acuity was significantly decreased, most cases recovered to baseline acuity within 1 month with topical corticosteroid treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Systemic or periocular steroids are rarely utilized [2, 11, 14, 23, 24].”
From Mechanisms of sterile inflammation after intravitreal injection of antiangiogenic drugs: a narrative review (2021) · cites this paper as [23]
Citations
Cites
Ranibizumab for Neovascular Age-Related Macular Degeneration
Rosenfeld, P. J., Brown, D. M., Heier, J. S., Boyer, D. S., Kaiser, P. K., Chung, C. Y., & Kim, R. Y. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054481 · Cited by 5,886
Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration
Brown, D. M., Kaiser, P. K., Michels, M., Soubrane, G., Heier, J. S., Kim, R. Y., Sy, J. P., & Schneider, S. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062655 · Cited by 3,522
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
Martin, D. F., Maguire, M. G., Fine, S. L., Ying, G.-S., Jaffe, G. J., Grunwald, J. E., Toth, C., Redford, M., & Ferris, F. L. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.03.053 · Cited by 1,715
Proper Method for Calculating Average Visual Acuity
Holladay, J. T. (1997) · Journal of Refractive Surgery · doi:10.3928/1081-597x-19970701-16 · Cited by 1,090
Fung, A. E., Rosenfeld, P. J., & Reichel, E. (2006) · British Journal of Ophthalmology · doi:10.1136/bjo.2006.099598 · Cited by 532
Wu, L., Martínez-Castellanos, M. A., Quiroz-Mercado, H., Arevalo, J. F., Berrocal, M. H., Farah, M. E., Maia, M., Roca, J. A., Rodriguez, F. J., & for the Pan American Collaborative Retina Group (PACORES) (2007) · Graefe's Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-007-0660-z · Cited by 456
Heier, J. S. (2006) · Archives of Ophthalmology · doi:10.1001/archopht.124.11.1532 · Cited by 304
Complications in patients after intravitreal injection of bevacizumab
Shima, C., Sakaguchi, H., Gomi, F., Kamei, M., Ikuno, Y., Oshima, Y., Sawa, M., Tsujikawa, M., Kusaka, S., & Tano, Y. (2008) · Acta Ophthalmologica · doi:10.1111/j.1600-0420.2007.01067.x · Cited by 200
Wickremasinghe, S. S., Michalova, K., Gilhotra, J., Guymer, R. H., Harper, C. A., Wong, T. Y., & Qureshi, S. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2008.05.007 · Cited by 124
Georgopoulos, M., Polak, K., Prager, F., Prunte, C., & Schmidt-Erfurth, U. (2009) · British Journal of Ophthalmology · doi:10.1136/bjo.2008.138479 · Cited by 124
Cited by
Baumal, C. R., Bodaghi, B., Singer, M. A., Tanzer, D. J., Seres, A., Joshi, M. R., Feltgen, N., & Gale, R. P. (2020) · Ophthalmology Retina · doi:10.1016/j.oret.2020.09.020 · Cited by 161
Anderson, W. J., da Cruz, N. F. S., Lima, L. H., Emerson, G. G., Rodrigues, E. B., & Melo, G. B. (2021) · International Journal of Retina and Vitreous · doi:10.1186/s40942-021-00307-7 · Cited by 155
Aflibercept-Related Sterile Intraocular Inflammation Outcomes
Greenberg, J. P., Belin, P., Butler, J., Feiler, D., Mueller, C., Tye, A., Friedlander, S. M., Emerson, G. G., & Ferrone, P. J. (2019) · Ophthalmology Retina · doi:10.1016/j.oret.2019.04.006 · Cited by 69
Kiss, S., Dugel, P. U., Khanani, A. M., Broder, M. S., Chang, E. Y., Sun, G. H., & Turpcu, A. (2018) · Clinical ophthalmology · doi:10.2147/opth.s169143 · Cited by 74
SHORT-TERM SAFETY PROFILE OF INTRAVITREAL ZIV-AFLIBERCEPT
Chhablani, J. K., Narayanan, R., Mathai, A., Yogi, R., & Stewart, M. (2015) · Retina · doi:10.1097/iae.0000000000000913 · Cited by 52
Metadata
- Authors
- Fine, H. F., Roth, D. B., Shah, S. P., Haque, T., & Wheatley, H. M.
- Affiliations
- Rutgers, The State University of New Jersey (US)
- Venue
- Retina
- Published
- 2015-04
- Volume
- 35
- Issue
- 4
- Pages
- 681-686
- ISSN
- 0275-004X (ISSN-L)
- OpenAlex
- W2316338492
- Cited by
- 37
- References
- 22
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 2 · 2023: 1 · 2022: 4 · 2021: 3 · 2020: 6 · 2019: 4 · 2018: 1 · 2017: 1 · 2016: 3 · 2015: 4
- FWCI
- 2.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Retina (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
- Keywords
- aflibercept, intravitreal injection, intraocular inflammation, adverse events, topical corticosteroids, visual acuity, vitreous culture, anti-VEGF therapy
- MeSH terms
- Aged, Aged, 80 and over, Female, Humans, Inflammation, Macular Edema, Male, Middle Aged, Endophthalmitis, Recombinant Fusion Proteins, Retinal Vein Occlusion, Retrospective Studies, Visual Acuity, Incidence, Angiogenesis Inhibitors, Receptors, Vascular Endothelial Growth Factor, Vascular Endothelial Growth Factor A, Wet Macular Degeneration, Intravitreal Injections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: FREQUENCY AND CHARACTERISTICS OF INTRAOCULAR INFLAMMATION AFTER AFLIBERCEPT INJECTION. https://app.cochat.ai/papers/10.1097/iae.0000000000000398
- The paper
- Fine, H. F., Roth, D. B., Shah, S. P., Haque, T., & Wheatley, H. M. (2015). FREQUENCY AND CHARACTERISTICS OF INTRAOCULAR INFLAMMATION AFTER AFLIBERCEPT INJECTION. Retina. https://doi.org/10.1097/iae.0000000000000398
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.